Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA).
The literature remains conflicted regarding the most effective way to screen for MRSA. This study was designed to assess costs associated with universal versus risk factor-based screening for the reduction of nosocomial MRSA transmission.The study was conducted at The Ottawa Hospital, a large multi-...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4963093?pdf=render |
| _version_ | 1818608014822735872 |
|---|---|
| author | Virginia R Roth Tara Longpre Doug Coyle Kathryn N Suh Monica Taljaard Katherine A Muldoon Karamchand Ramotar Alan Forster |
| author_facet | Virginia R Roth Tara Longpre Doug Coyle Kathryn N Suh Monica Taljaard Katherine A Muldoon Karamchand Ramotar Alan Forster |
| author_sort | Virginia R Roth |
| collection | DOAJ |
| description | The literature remains conflicted regarding the most effective way to screen for MRSA. This study was designed to assess costs associated with universal versus risk factor-based screening for the reduction of nosocomial MRSA transmission.The study was conducted at The Ottawa Hospital, a large multi-centre tertiary care facility with approximately 47,000 admissions annually. From January 2006-December 2007, patients underwent risk factor-based screening for MRSA on admission. From January 2008 to August 2009 universal MRSA screening was implemented. A comparison of costs incurred during risk factor-based screening and universal screening was conducted. The model incorporated probabilities relating to the likelihood of being tested and the results of polymerase chain reaction (PCR) testing with associated effects in terms of MRSA bacteremia and true positive and negative test results. Inputted costs included laboratory testing, contact precautions and infection control, private room costs, housekeeping, and length of hospital stay. Deterministic sensitivity analyses were conducted.The risk factor-based MRSA screening program screened approximately 30% of admitted patients and cost the hospital over $780 000 annually. The universal screening program screened approximately 83% of admitted patients and cost over $1.94 million dollars, representing an excess cost of $1.16 million per year. The estimated additional cost per patient screened was $17.76.This analysis demonstrated that a universal MRSA screening program was costly from a hospital perspective and was previously known to not be clinically effective at reducing MRSA transmission. These results may be useful to inform future model-based economic analyses of MRSA interventions. |
| first_indexed | 2024-12-16T14:35:55Z |
| format | Article |
| id | doaj.art-092779afcf8e427cb91d23543d267d75 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-16T14:35:55Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-092779afcf8e427cb91d23543d267d752022-12-21T22:28:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015966710.1371/journal.pone.0159667Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA).Virginia R RothTara LongpreDoug CoyleKathryn N SuhMonica TaljaardKatherine A MuldoonKaramchand RamotarAlan ForsterThe literature remains conflicted regarding the most effective way to screen for MRSA. This study was designed to assess costs associated with universal versus risk factor-based screening for the reduction of nosocomial MRSA transmission.The study was conducted at The Ottawa Hospital, a large multi-centre tertiary care facility with approximately 47,000 admissions annually. From January 2006-December 2007, patients underwent risk factor-based screening for MRSA on admission. From January 2008 to August 2009 universal MRSA screening was implemented. A comparison of costs incurred during risk factor-based screening and universal screening was conducted. The model incorporated probabilities relating to the likelihood of being tested and the results of polymerase chain reaction (PCR) testing with associated effects in terms of MRSA bacteremia and true positive and negative test results. Inputted costs included laboratory testing, contact precautions and infection control, private room costs, housekeeping, and length of hospital stay. Deterministic sensitivity analyses were conducted.The risk factor-based MRSA screening program screened approximately 30% of admitted patients and cost the hospital over $780 000 annually. The universal screening program screened approximately 83% of admitted patients and cost over $1.94 million dollars, representing an excess cost of $1.16 million per year. The estimated additional cost per patient screened was $17.76.This analysis demonstrated that a universal MRSA screening program was costly from a hospital perspective and was previously known to not be clinically effective at reducing MRSA transmission. These results may be useful to inform future model-based economic analyses of MRSA interventions.http://europepmc.org/articles/PMC4963093?pdf=render |
| spellingShingle | Virginia R Roth Tara Longpre Doug Coyle Kathryn N Suh Monica Taljaard Katherine A Muldoon Karamchand Ramotar Alan Forster Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). PLoS ONE |
| title | Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). |
| title_full | Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). |
| title_fullStr | Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). |
| title_full_unstemmed | Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). |
| title_short | Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA). |
| title_sort | cost analysis of universal screening vs risk factor based screening for methicillin resistant staphylococcus aureus mrsa |
| url | http://europepmc.org/articles/PMC4963093?pdf=render |
| work_keys_str_mv | AT virginiarroth costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT taralongpre costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT dougcoyle costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT kathrynnsuh costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT monicataljaard costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT katherineamuldoon costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT karamchandramotar costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa AT alanforster costanalysisofuniversalscreeningvsriskfactorbasedscreeningformethicillinresistantstaphylococcusaureusmrsa |